Could CRISPR Fix this Severe Childhood Brain Disorder? A technology that activates healthy genes reduced seizures in a mouse model of a severe genetic neurological condition. When brain development ...
Researchers from Children's Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) have compiled a complete genetic and clinical analysis of more than 400 ...
SCN2A related-disorders, although rare in the general population, are one of the more common single-gene neurodevelopmental conditions characterized by infantile seizures, autism spectrum disorder and ...
New Study in Journal, Brain, Reveals Expanded Clinical Phenotype Spectrum in SCN2A-related disorders
GETTYSBURG, PA, UNITED STATES, April 26, 2024 /EINPresswire.com/ -- A groundbreaking study newly published in Brain, "Expanded clinical phenotype spectrum correlates ...
A genetic change or variant in a gene called SCN2A is a known cause of infantile seizures, autism spectrum disorder and intellectual disability, as well as a wide range of other moderate-to-profound ...
CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of ...
The DRAGONFLY Study is launching soon. The FamilieSCN2A Foundation - learn the difference 'families' make. Alone, we are rare. Together, we are strong. Global research study plans to accelerate ...
PITTSBURGH, January 28, 2026--(BUSINESS WIRE)--The SCN2A Foundation today announced a research collaboration with Unravel Biosciences, Inc., an AI-enabled therapeutics company established to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results